首页   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Ephrin Receptor

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

Ephrin Receptor

结构式 货号 产品名称 CAS号
123C4 结构式
BCP44969 123C4 2034159-30-1
123C4 is a novel, potent, and selective agonist of the tyrosine kinase EphA4 receptor.
NVP-BHG712 isomer 结构式
BCP43510 NVP-BHG712 isomer 2245892-85-5
NVP-BHG712 isomer, a regioisomer of NVP-BHG712, shows conserved non-bonded binding to EPHA2 and EPHB4.
JI-101 结构式
BCP16892 JI-101 900573-88-8
JI-101 is a n orally active inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor beta (PDGFRb), and the ephrin B4 receptor B4 (EphB4) with potential antiangiogenic and antineoplastic activities.
NVP-BHG712 结构式
BCP02362 NVP-BHG712 940310-85-0
NVP-BHG712 is a small molecule specific EphB4, VEGFR2, c-raf, c-src and c-Abl kinase inhibitor with ED50 of 25 nM, 4.2, 0.4, 1.3 and 1.7μM, respectively.
Tesevatinib 结构式
BCP23438 Tesevatinib 781613-23-8
XL-647 (Tesevatinib, EXEL-7647, KD-019) is a novel spectrum-selective kinase inhibitor that potently inhibits the EGFR, ErbB2, KDR and EphB4 with IC50 of 0.3, 16, 1.5 and 1.4 nM, respectively.
XL647(Racemate) 结构式
BCP02839 XL647(Racemate) 874286-84-7
XL-647 (Tesevatinib;XL-647;KD-019) is an orally available, multi-target tyrosine kinase inhibitor; inhibits EGFR, ErbB2, KDR, Flt4 and EphB4 kinase with IC50s of 0.3, 16, 1.5, 8.7, and 1.4 nM.
 ALW-II-41-27 结构式
BCP26205 ALW-II-41-27 1186206-79-0
ALW-II-41-27 is a Eph receptor tyrosine kinase inhibitor.
2853530910